Progression to dementia in memory clinic patients with mild cognitive impairment and normal β-amyloid

Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report

(2019) Peter T Nelson et al.   BRAIN

Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study

(2019) Ingrid S van Maurik et al.   LANCET NEUROLOGY

Biomarker-guided clustering of Alzheimer's disease clinical syndromes

(2019) Nicola Toschi et al.   NEUROBIOLOGY OF AGING

Upward drift in cerebrospinal fluid amyloid β 42 assay values for more than 10 years

(2018) Suzanne E. Schindler et al.   Alzheimers & Dementia

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

(2018) Clifford R. Jack et al.   Alzheimers & Dementia

Memory decline accompanies subthreshold amyloid accumulation

(2018) Susan M. Landau et al.   NEUROLOGY

Concordance Between Cerebrospinal Fluid Biomarkers and [11C]PIB PET in a Memory Clinic Cohort

(2018) Marissa Zwan et al.   JOURNAL OF ALZHEIMERS DISEASE

Age dependency of risk factors for cognitive decline

(2018) N. Legdeur et al.   BMC Geriatrics

Regional amyloid accumulation and cognitive decline in initially amyloid-negative adults

(2018) Michelle E. Farrell et al.   NEUROLOGY

The frequency and influence of dementia risk factors in prodromal Alzheimer's disease

(2017) Isabelle Bos et al.   NEUROBIOLOGY OF AGING

Blood pressure from mid‐ to late life and risk of incident dementia

(2017) Emer R. McGrath et al.   NEUROLOGY

Unbiased estimates of cerebrospinal fluid β-amyloid 1–42 cutoffs in a large memory clinic population

(2017) Daniela Bertens et al.   Alzheimers Research & Therapy

Association of Longitudinal Cognitive Decline With Amyloid Burden in Middle-aged and Older Adults

(2017) Michelle E. Farrell et al.   JAMA Neurology

Interpreting Biomarker Results in Individual Patients With Mild Cognitive Impairment in the Alzheimer’s Biomarkers in Daily Practice (ABIDE) Project

(2017) Ingrid S. van Maurik et al.   JAMA Neurology

Suspected non-Alzheimer disease pathophysiology — concept and controversy

(2016) Clifford R. Jack et al.   Nature Reviews Neurology

CAIDE Dementia Risk Score and biomarkers of neurodegeneration in memory clinic patients without dementia

(2016) Daniela Enache et al.   NEUROBIOLOGY OF AGING

Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer’s disease

(2016) Panagiotis Alexopoulos et al.   Alzheimers Research & Therapy

Prevalence and prognosis of Alzheimer’s disease at the mild cognitive impairment stage

(2015) Stephanie J. B. Vos et al.   BRAIN

Risk factors for predicting progression from mild cognitive impairment to Alzheimer’s disease: a systematic review and meta-analysis of cohort studies

(2015) Jie-Qiong Li et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Mild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progression

(2015) A. Caroli et al.   NEUROLOGY

SveDem, the Swedish Dementia Registry – A Tool for Improving the Quality of Diagnostics, Treatment and Care of Dementia Patients in Clinical Practice

(2015) Dorota Religa et al.   PLoS One

Advances in the prevention of Alzheimer's disease and dementia

(2014) A. Solomon et al.   JOURNAL OF INTERNAL MEDICINE

Mild cognitive impairment: a concept in evolution

(2014) R. C. Petersen et al.   JOURNAL OF INTERNAL MEDICINE

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

(2014) Bruno Dubois et al.   LANCET NEUROLOGY

Midlife risk score for the prediction of dementia four decades later

(2013) Lieza G. Exalto et al.   Alzheimers & Dementia

Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI

(2013) S. J. B. Vos et al.   NEUROLOGY

Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease

(2013) A. Prestia et al.   NEUROLOGY

Cognitive reserve in ageing and Alzheimer's disease

(2012) Yaakov Stern   LANCET NEUROLOGY

Age and diagnostic performance of Alzheimer disease CSF biomarkers

(2012) N. Mattsson et al.   NEUROLOGY

Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Clifford R. Jack et al.   Alzheimers & Dementia

Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Reisa A. Sperling et al.   Alzheimers & Dementia

The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Marilyn S. Albert et al.   Alzheimers & Dementia

Predictive value of APOE- 4 allele for progression from MCI to AD-type dementia: a meta-analysis

(2011) L. S. Elias-Sonnenschein et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease

(2010) C. R. Jack et al.   BRAIN

Revising the definition of Alzheimer's disease: a new lexicon

(2010) Bruno Dubois et al.   LANCET NEUROLOGY

Rate of progression of mild cognitive impairment to dementia - meta-analysis of 41 robust inception cohort studies

(2009) A. J. Mitchell et al.   ACTA PSYCHIATRICA SCANDINAVICA

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

(2009) Clifford R Jack et al.   LANCET NEUROLOGY